For full functionality of this page it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser FDA Tag Archives | Page 2 of 4
US Flag
UK Flag Canada Flag

Tag: FDA

Aug
22

Recalls Remain Steady as Regulators are in the Hot Seat

The big story from the Q2 2019 Recall Index we’ve just released isn’t as much about the number of events or units recalled as it is the recall environment companies are finding themselves in. While Congress focuses on safety-related regulatory processes at the CPSC, and FDA tries to find its way on matters related to cannabis and CBD oil, companies are finding a regulator that is stricter and more sensitive to pressure from lawmakers.

Continue Reading
Jun
25

Closer FDA CBD Product Regulation – and Recalls – Appear Inevitable

We’ve seen sweeping regulatory changes before, but the FDA’s anticipated regulation of cannabis and CBD-infused products – a market expected to reach more than $20B globally by 2024 – promises to pose significant and unprecedented challenges to food and cosmetics manufacturers already using cannabidiol as an ingredient.

Continue Reading
Jun
11

Recalls in the Era of Fake News

Fake product recalls – unlike other claims of so-called “fake news” – are exceedingly rare. But they are not without precedence. Just last year, a car dealership in Washington, D.C., was heavily fined by the Federal Trade Commission for sending fake recall warnings to car owners in the hopes of drumming up more business for the dealership’s repair shop. The dealership sent out bright red mailers that mimicked official recall notices from the National Highway Traffic Safety Administration (NHTSA).

Continue Reading
Apr
16

How Emerging Technologies Can Both Improve and Exacerbate Product Recalls

Advances in technology tend to be mixed blessings for product recalls. They often introduce new product safety vulnerabilities while, at the same time, may offer new capabilities that improve recall efficacy. The impact of technologies like artificial intelligence (AI), Internet of Things (IoT), robotics, big data, and others on product recalls are slowly unfolding, but emerging patterns give us some sense about how these technologies might affect product safety and recall management in the future.

Continue Reading
Apr
09

FDA Playing Catch-Up As Growers and Manufacturers Wait to See How CBD Will Be Regulated

In December of 2018, Congress passed the farm bill, which, among other things, broadened the ways in which hemp can be cultivated and transported. While hemp can be used to create a variety of products, the market for cannabidiol, a hemp extract commonly known as CBD, is attracting the most attention by far. CBD is said to promote relaxation without the psychoactive effects of the THC compound found in marijuana, and manufacturers have been adding the compound to everything from beverages to shampoo since the bill passed.

Continue Reading